CoverageForm 410-K10-Q8-K13D13G13F

Palvella Therapeutics, Inc.

CIK 0001583648
President and CEODirector

Filings

4

Latest Feb 7, 2025

Issuers covered

1

Showing

4 of 4

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Palvella Therapeutics, Inc.. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Palvella Therapeutics, Inc. has filed

TickerIssuerFilingsLast filed
PIRSPieris Pharmaceuticals, Inc.4Feb 7, 2025

All filings

4 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue